- Home
- MRK vs CXAIW Comparison
MRK vs CXAIW Comparison
Compare MRK & CXAIW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MRK
- CXAIW
- Stock Information
- Founded
- MRK 2000
- CXAIW N/A
- Country
- MRK United States
- CXAIW United States
- Employees
- MRK N/A
- CXAIW 41
- Industry
- MRK Biotechnology: Pharmaceutical Preparations
- CXAIW EDP Services
- Sector
- MRK Health Care
- CXAIW Technology
- Exchange
- MRK Nasdaq
- CXAIW Nasdaq
- Market Cap
- MRK 198.5B
- CXAIW N/A
- IPO Year
- MRK N/A
- CXAIW N/A
- Fundamental
- Price
- MRK $83.30
- CXAIW $0.07
- Analyst Decision
- MRK Buy
- CXAIW
- Analyst Count
- MRK 15
- CXAIW 0
- Target Price
- MRK $113.14
- CXAIW N/A
- AVG Volume (30 Days)
- MRK 18.0M
- CXAIW 20.9K
- Earning Date
- MRK 07-29-2025
- CXAIW 03-21-2025
- Dividend Yield
- MRK 3.89%
- CXAIW N/A
- EPS Growth
- MRK 667.14
- CXAIW N/A
- EPS
- MRK 6.88
- CXAIW N/A
- Revenue
- MRK $63,922,000,000.00
- CXAIW $7,200,000.00
- Revenue This Year
- MRK $2.42
- CXAIW N/A
- Revenue Next Year
- MRK $5.77
- CXAIW N/A
- P/E Ratio
- MRK $12.12
- CXAIW N/A
- Revenue Growth
- MRK 4.10
- CXAIW N/A
- 52 Week Low
- MRK $73.31
- CXAIW $0.11
- 52 Week High
- MRK $129.93
- CXAIW $0.14
- Technical
- Relative Strength Index (RSI)
- MRK 60.59
- CXAIW N/A
- Support Level
- MRK $80.15
- CXAIW N/A
- Resistance Level
- MRK $85.00
- CXAIW N/A
- Average True Range (ATR)
- MRK 1.84
- CXAIW 0.00
- MACD
- MRK 0.37
- CXAIW 0.00
- Stochastic Oscillator
- MRK 75.22
- CXAIW 0.00
About MRK Merck & Company Inc. (new)
Merck makes pharmaceutical products to treat several conditions in a number of therapeutic areas, including cardiometabolic disease, cancer, and infections. Within cancer, the firm's immuno-oncology platform is growing as a major contributor to overall sales. The company also has a substantial vaccine business, with treatments to prevent pediatric diseases as well as human papillomavirus, or HPV. Additionally, Merck sells animal health-related drugs. From a geographical perspective, just under half of the company's sales are generated in the United States.
About CXAIW CXApp Inc. Warrant
CXApp Inc is a provider of AI-powered employee experience solutions, delivering enterprise-grade software that enhances workplace engagement, productivity, and operational efficiency. The company's flagship product, the CXAI Platform, provides a comprehensive suite of tools designed to empower employees and enable organizations to create smarter workplaces. The product's key components include CXAI Apps, CXAI BTS, and CXAI-VU. The company generates the majority of its revenue from Licenses.